Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01237821 · ClinicalTrials.gov registry record · NA
Comparing OTC Acne Treatment to Prescription Regimen
A NA study, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 66
- Enrollment target
NCT01237821 is a NA study that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 66 participants.
The verdict
NCT01237821, a NA study, has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
Study Summary
This research is being done to find out the safety and efficacy of two acne creams, Effaclar and Benzaclin when used twice daily with a topical retinoid. Effaclar and Benzaclin are FDA approved for the treatment of acne.
Interventions
- DRUG BenzaClin
- DRUG Effaclar
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2010-10 |
| Est. Completion | 2011-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01237821
The ClinicalTrials.gov registry entry for NCT01237821 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which BenzaClin is the first listed.
NCT01237821 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01237821 about?
NCT01237821 is a clinical study titled "Comparing OTC Acne Treatment to Prescription Regimen". This research is being done to find out the safety and efficacy of two acne creams, Effaclar and Benzaclin when used twice daily with a topical retinoid. Effaclar and Benzaclin are FDA approved for the treatment of acne.
What is the current status of trial NCT01237821?
This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2010-10. Estimated completion is 2011-10.
What interventions are being tested in trial NCT01237821?
The interventions under investigation include: BenzaClin (DRUG), Effaclar (DRUG).
Who is sponsoring clinical trial NCT01237821?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.